Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
56
HSA:43
NMPA:13
Drug Approvals
Propafenone Hydrochloride Tablets
- Product Name
- 悦复隆
- Approval Number
- 国药准字HJ20160339
- Approval Date
- Jul 1, 2024
NMPA
Clarithromycin Granules for Oral Suspension
- Product Name
- Klacid
- Approval Number
- 国药准字HJ20160416
- Approval Date
- Nov 14, 2023
NMPA
Terazosin Hydrochloride Tablets
- Product Name
- 高特灵
- Approval Number
- 国药准字HJ20171357
- Approval Date
- Jul 22, 2021
NMPA
Terazosin Hydrochloride Tablets
- Product Name
- 高特灵
- Approval Number
- 国药准字HJ20181009
- Approval Date
- Jul 22, 2021
NMPA
Clarithromycin Sustained Release Tablets
- Product Name
- 克拉仙
- Approval Number
- H20181041
- Approval Date
- May 6, 2020
NMPA
Propafenone Hydrochloride Tablets
- Product Name
- 悦复隆
- Approval Number
- 国药准字J20200004
- Approval Date
- Feb 7, 2020
NMPA
Propafenone Hydrochloride Tablets
- Product Name
- 悦复隆
- Approval Number
- H20201001
- Approval Date
- Jan 7, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found